RxDoctor Payments Data

Antonio Martinez, MD

Family Medicine · Harlingen, TXNPI 1497012926

Payments from drug & device makers

$242in general payments, 2019–2025

Across 12 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$51
  • Novo Nordisk$48
  • Lilly USA, LLC$47
  • Abiomed$33
  • Exact Sciences$17
  • Dexcom, Inc.$17
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$242100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$242 in reported general payments places this provider in the 35th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$61,072
Medicare patients
116
Services billed
787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide110$177,029
MounjaroTirzepatide24$23,814
EliquisApixaban30$21,550
LinzessLinaclotide18$19,417
Tresiba Flextouch U-100Insulin Degludec28$16,389
Tresiba Flextouch U-200Insulin Degludec17$11,099
TradjentaLinagliptin13$10,359
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$5,329
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen207$5,309
Celecoxib76$5,284
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip92$2,477
Atorvastatin Calcium204$2,068
Gabapentin111$2,057
Pregabalin12$1,826
Omeprazole81$1,822

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$48$177,029110 claims
Lilly USA, LLCMounjaro$47$23,81424 claims
AbbVieLinzess$13$19,41718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Harlingen

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →